ARA-290

Erythropoietin-Derived Tissue-Protective Peptide & Neuroprotection Research Compound

Product Overview

Ara-290 16mg is an 11-amino-acid research peptide engineered from erythropoietin (EPO). It is specifically designed to selectively activate tissue-protective receptors without stimulating erythropoiesis (the production of red blood cells). Produced using state-of-the-art synthesis techniques, Ara-290 provides researchers with a reliable tool for investigating complex inflammatory and neurodegenerative processes.

Key Research Applications

• Neuroprotection Mechanisms: Primarily utilized to explore protective pathways in peripheral neuropathy models.

• Anti-Inflammatory Research: Targeted in studies investigating tissue-repair pathways and the modulation of inflammation following ischemic injury.

• Microvascular Repair: Frequently used to assess potential benefits in studies focusing on microvascular dysfunction and blood flow.

• Neuropathic Pain Mitigation: Evaluated for its capacity to enhance nerve regeneration and reduce pain signaling in experimental systems.

• Wound Healing Dynamics: Serves as an analytical tool for observing peptide-mediated tissue protection during the wound recovery process.

Why Researchers Choose Ara-290

• Non-Hematopoietic Selectivity: Offers a unique model for tissue protection that avoids the side effects of red blood cell stimulation associated with standard EPO.

• Verified Analytical Purity: Manufactured under stringent standards to ensure a purity of ≥99%, providing consistent and dependable data.

• Preserved Bioactivity: Supplied in a lyophilized powder format to maintain molecular stability and efficacy during transport and storage.

Technical Specifications

• Molecular Formula: C51_​H84_​N16_​O21​

• Molecular Weight: 1257.31 g/mol

• Sequence: Glp-Glu-Gln-Leu-Glu-Arg-Ala-Leu-Asn-Ser-Ser

• CAS Number: 1208243-50-8

• Solubility: Soluble in water or 1% acetic acid.

Research Notice: Ara-290 16mg is strictly for laboratory and scientific research use only. It is not approved for human or animal consumption, medical treatment, or therapeutic use.

---

Validated Synthesis & Expedited Fulfillment

Clinical-Grade Synthesis & Purity

Our RUO peptides are engineered via precision synthesis, utilizing meticulously validated protocols to ensure uncompromising accuracy and batch-to-batch consistency. To maintain verified purity, every production lot undergoes independent third-party analysis—including HPLC and mass spectrometry—to confirm molecular identity and a purity of >99%. For expedited research timelines, we provide same-day fulfillment from our U.S. facility for orders placed before 12 PM PST, ensuring rapid and reliable delivery.